Latest Breaking News On - Ann rheum - Page 2 : comparemela.com

Guselkumab Improves Skin Disease Activity, Baseline Arthritis in TNF-IR PsA

At week 24, patients receiving guselkumab had significant decreases in C-reactive protein and effector cytokines linked to the interleukin-23 (IL-23)/IL-17 levels compared with patients in the placebo cohort.

Georg schettDepartment of internal medicineFriedrich alexander university erlangenArthritis researchAmerican college of rheumatologyFriedrich alexander university erlangen nAmerican collegeInternal medicinePsoriasis areaSeverity indexArthritis resDanish nationwideAnn rheum

Trethera Receives Grant from National Institute of Allergy and Infectious Diseases for the Advancement of TRE-515 in Lupus

Trethera Receives Grant from National Institute of Allergy and Infectious Diseases for the Advancement of TRE-515 in Lupus
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Ken schultzPeter clarkTrethera corporationM small business technology transferNational institute for allergySmall business technology transferNational instituteInfectious diseasesInvestigational new drugScientific advisoryAnn rheumInvestor relationsPrivate securities litigation reform act

Trethera Receives Grant from National Institute of Allergy

LOS ANGELES, June 27, 2023 (GLOBE NEWSWIRE) Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs.

Ken schultzPeter clarkTrethera corporationNational institute for allergyM small business technology transferSmall business technology transferNational instituteInfectious diseasesInvestigational new drugScientific advisoryAnn rheumInvestor relationsPrivate securities litigation reform act

Trethera Receives Grant from National Institute of Allergy and Infectious Diseases for the Advancement of TRE-515 in Lupus

Trethera Receives Grant from National Institute of Allergy and Infectious Diseases for the Advancement of TRE-515 in Lupus
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Peter clarkKen schultzTrethera corporationNational institute for allergyM small business technology transferSmall business technology transferNational instituteInfectious diseasesInvestigational new drugScientific advisoryAnn rheumInvestor relationsPrivate securities litigation reform act

Risankizumab Provides Durable Quality of Life Improvements out to 100 Weeks in Psoriatic Arthritis

An analysis of 100 week data from the KEEPsAKE 1 and 2 trials presented at EULAR 2023 offers insight into the long-term effects of risankizumab use in people with psoriatic arthritis.

Lars erik kristensenEli lillyParker instituteEuropean congressBristol myers squibbEuropean congress on rheumatologyAnn rheum